Heart function and inflammation in lupus kidney disease
Part of Heart & circulation, Immune system & allergy, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This study looks at how the heart relaxes between beats (diastolic function) and measures certain blood markers of inflammation in people with lupus-related kidney disease who are in the intensive care unit (ICU). It aims to learn more about how lupus and inflammation affect the heart, which could lead to better treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or older.
- Have a confirmed diagnosis of lupus (systemic lupus erythematosus).
- Have lupus-related kidney disease (lupus nephritis), confirmed by biopsy or clinical diagnosis.
- Be currently in the intensive care unit (ICU) for any reason.
- Not have a pre-existing heart condition unrelated to lupus.
- Not have an irregular heartbeat like atrial fibrillation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses an ultrasound to measure kidney blood flow in people with lupus kidney disease. The goal is to see if this simple test can tell how active the disease is, which might help doctors adjust treatment without needing frequent biopsies.
This study looks at a simple blood test (called the Systemic Immune Inflammatory Index) to see if it can help doctors understand how active lupus is in your body. It includes people with lupus, especially those with kidney involvement, to find better ways to track the disease.
This study looks at blood and urine markers that may show how active lupus kidney disease is and how it changes over time. It may help doctors better monitor people with active lupus-related kidney inflammation.
This study looks at whether simple blood tests can help doctors better understand and track kidney problems that occur in people with lupus. The goal is to see if these markers can predict how the disease will progress, which could help guide treatment.
This study aims to find better ways to detect kidney problems in people with lupus by testing blood and urine samples. If you have lupus, you may help researchers improve how kidney disease is diagnosed and monitored.
This study is looking for biomarkers (clues in your blood, urine, or tissue) that can help predict how well lupus nephritis (kidney inflammation caused by lupus) responds to treatment. It focuses on people who have active kidney disease and are either starting treatment or have been on a stable treatment for at least a month.
Hear when a new Lupus Nephritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.